ClinicalTrials.gg
Active, not recruitingNCT04039750PA protocolUpdated Jan 27, 2026

Use of Antibiotic Irrigation to Decrease Wound Infections in Pediatric Perforated Appendicitis

A Phase 2 interventional study of antibiotic rinse with suction and suction only in Perforated Appendicitis, sponsored by Prisma Health-Upstate. Active, not recruiting at 1 site in United States. Open to participants aged 0 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-01-27.

Sponsored by Prisma Health-Upstate · Phase 2, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
0 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 78 studies in Appendicitis with a site in United States — 6 open to participants now, 10 under way, none of them phase 3. Appendicitis · United States.

Planned enrollment
17th of 59
200 · median 98
Started
2019
with 2 others
Phase 2
5 of 78
none open now
Registered
55th of 78
by date

Among the 78 studies in Appendicitis with a site in United States, this one is the 17th largest by planned enrollment of the 59 interventional ones that give a count, is one of 3 that started in 2019, is one of 5 in phase 2, and was the 55th registered.

Appendicitis

421 studies on the registry are indexed under Appendicitis; 67 are open to participants now.

Browse Appendicitis studies →

Open to participants now

6 of the 78 studies in Appendicitis with a site in United States are open now. Recruiting first, the newest first:

1 more — sign in →

All 6 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 39 Appendicitis studies recruiting now, 18 (46%) set no upper age limit and 19 (49%) stop at 75 or younger; 23 take children under 18; 7 take healthy volunteers.

This study: 0 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 78 studies in Appendicitis with a site in United States, or all of them as a file.
02

Study summary

The proposed study will investigate whether antibiotic irrigation using a gentamicin/clindamycin solution during laparoscopic appendectomy is superior in preventing postoperative wound infections and IAA in perforated appendicitis compared to suction without irrigation. This will be the first prospective study to compare these two options in pediatric PA.

Read the detailed description

This study is for pediatric patients who are having an appendectomy and have a perforated appendix. The purpose of this study is to see whether antibiotic irrigation using gentamicin, clindamycin and suction during the surgery works better when compared to suction alone when cleaning the stomach cavity.

Arm A patients will have their abdomen irrigated with the antibiotics, gentamycin and clindamycin, and then the wound will be suctioned out. Arm B patients will not have the antibiotic irrigation but will have their wound suctioned.

03

Conditions studied

  • Perforated Appendicitis

Browse trials for

04

Who can participate

Ages eligible
0 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Male or female, age 18 years or younger
  2. Scheduled to undergo laparoscopic appendectomy
  3. Preoperative or intra-operative diagnosis of perforated appendicitis (PA).
  4. Willingness to undergo treatments, provide written , and participate in follow-up.

Exclusion criteria

Exclusion Criteria:

  1. Male or female older than 18 years of age
  2. Declined to undergo laparoscopic appendectomy
  3. Not willing to provide written or undergo randomization of treatment
  4. Pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Antibiotic irrigation with suction

    Group A: You will receive antibiotic irrigation with suction if a PA is found during surgery

    Drug: antibiotic rinse with suction

  • Active comparator
    suction only

    Group B: You will receive suction alone if a PA is found during surgery

    Procedure: suction only

Interventions

  • Drugantibiotic rinse with suction

    antibiotic rinse with suction

    Also known as: Clindamycin, gentamycin

  • Proceduresuction only

    no irrigation, suction only

06

What researchers measure

Primary outcomes

  1. wound complications

    The overall objective is to change the postoperative wound complications and IAA after laparoscopic appendectomy for perforated appendicitis in pediatric patients. The outcome will be measured by tracking any wound complications that these patients have and comparing the incidence between treatment arms

    Time frame: 30 days

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2019 (actual). Primary completion is estimated for Dec 2026, 89 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 26, 2019
First posted
Jul 31, 2019
StartActual
Jul 25, 2019
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Jan 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04039750
Lead sponsor
Prisma Health-Upstate
Responsible party
Sponsor
First posted
Jul 31, 2019
Start date
Jul 25, 2019
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jan 27, 2026

Study contacts

Robert Gates, MD
principal investigator · Prisma Health

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion